# A Study of Bioavailability and Food Effect of SACT-1 and Edurant® Tablets in Healthy Adult Volunteers

> **NCT05358756** · PHASE1 · COMPLETED · sponsor: **Aptorum International Limited** · enrollment: 16 (actual)

## Conditions studied

- Healthy Subject

## Interventions

- **DRUG:** SACT-1
- **DRUG:** EDURANT 25Mg Tablet

## Key facts

- **NCT ID:** NCT05358756
- **Lead sponsor:** Aptorum International Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-10-09
- **Primary completion:** 2021-11-20
- **Final completion:** 2021-12-14
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2022-05-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05358756

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05358756, "A Study of Bioavailability and Food Effect of SACT-1 and Edurant® Tablets in Healthy Adult Volunteers". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT05358756. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*